Publications
| Title | Abstract | Year Filter | PMID(sorted descending) Filter |
|---|
| targeting the human parasite leishmania donovani: discovery of a new promising anti-infectious pharmacophore in 3-nitroimidazo[1,2-a]pyridine series. | we report herein the discovery of antileishmanial molecules based on the imidazo[1,2-a]pyridine ring. in vitro screenings of imidazopyridines belonging to our chemical library, toward the promastigotes stage of leishmania donovani, j774a.1 murine and hepg2 human cells, permitted to identify three selective hit-compounds (12, 20 and 28). new derivatives were then synthesized to allow structure-activity and -toxicity relationships analyses, enabling to characterize a lead-compound (44) displaying ... | 2013 | 24080103 |
| degree of anemia correlates with increased utilization of heme by leishmania donovani parasites in visceral leishmaniasis. | anemia in kala-azar patients is a serious problem. the present study has addressed this problem with the hypothesis that as the leishmania parasite is completely devoid of heme biosynthetic pathway, therefore the excessive use of heme by the parasites in the human patients can be one of the possible reason of anemia. we investigated that whether, the inability of leishmania donovani to synthesize heme, can enforce leishmania parasite to utilize heme derived from host sources in indian ka patient ... | 2013 | 24076432 |
| role of efflux pumps and intracellular thiols in natural antimony resistant isolates of leishmania donovani. | in view of the recent upsurge in the phenomenon of therapeutic failure, drug resistance in leishmania, developed under natural field conditions, has become a great concern yet little understood. accordingly, the study of determinants of antimony resistance is urgently warranted. efflux transporters have been reported in leishmania but their role in clinical resistance is still unknown. the present study was designed to elucidate the mechanism of natural antimony resistance in l. donovani field i ... | 2013 | 24069359 |
| the il-33/st2 axis is associated with human visceral leishmaniasis and suppresses th1 responses in the livers of balb/c mice infected with leishmania donovani. | during visceral leishmaniasis, the control of hepatic parasite burden is mainly due to granuloma assembly in a microenvironment consisting of both th1 and th2 components. using enzyme-linked immunosorbent assay (elisa) dosages, quantitative pcr (qpcr), immunohistochemistry, and flow cytometry, we studied the role of interleukin-33 (il-33), a recently described cytokine signaling through the st2 receptor, during visceral leishmaniasis. we showed that a higher level of il-33 was detected in the se ... | 2013 | 24045639 |
| novel role of calmodulin in regulating protein transport to mitochondria in a unicellular eukaryote. | lower eukaryotes like the kinetoplastid parasites are good models to study evolution of cellular pathways during steps to eukaryogenesis. in this study, a kinetoplastid parasite, leishmania donovani, was used to understand the process of mitochondrial translocation of a nucleus-encoded mitochondrial protein, the mitochondrial tryparedoxin peroxidase (mtxnpx). we report the presence of an n-terminal cleavable mitochondrial targeting signal (mts) validated through deletion and grafting experiments ... | 2013 | 24043313 |
| a transcriptomic network identified in uninfected macrophages responding to inflammation controls intracellular pathogen survival. | intracellular pathogens modulate host cell function to promote their survival. however, in vitro infection studies do not account for the impact of host-derived inflammatory signals. examining the response of liver-resident macrophages (kupffer cells) in mice infected with the parasite leishmania donovani, we identified a transcriptomic network operating in uninfected kupffer cells exposed to inflammation but absent from kupffer cells from the same animal that contained intracellular leishmania. ... | 2013 | 24034621 |
| vaccination with leishmania hemoglobin receptor-encoding dna protects against visceral leishmaniasis. | leishmaniasis is a severe infectious disease. drugs used for leishmaniasis are very toxic, and no vaccine is available. we found that the hemoglobin receptor (hbr) of leishmania was conserved across various strains of leishmania, and anti-hbr antibody could be detected in kala-azar patients' sera. our results showed that immunization with hbr-dna induces complete protection against virulent leishmania donovani infection in both balb/c mice and hamsters. moreover, hbr-dna immunization stimulated ... | 2013 | 24027025 |
| identification and characterization of the regions involved in the nuclear translocation of the heterodimeric leishmanial dna topoisomerase ib. | leishmania donovani, the causative organism for visceral leishmaniasis, contains a unique heterodimeric dna-topoisomerase ib (ldtopib). ldtopib is a heterodimer made up of a large subunit and a small subunit that must interact with each other to build an active enzyme able to solve the topological tensions on the dna. as ldtopib is located within the nucleus, one or more nuclear localization signals (nls) should exist to ensure its nuclear translocation. in this report three novel nls have been ... | 2013 | 24023887 |
| metabolic adaptations of leishmania donovani in relation to differentiation, drug resistance, and drug pressure. | antimonial (sodium stibogluconate, ssg) resistance and differentiation have been shown to be closely linked in leishmania donovani, with ssg-resistant strains showing an increased capacity to generate infectious (metacyclic) forms. this is the first untargeted lc-ms metabolomics study which integrated both phenomena in one experimental design and provided insights into metabolic differences between three clinical l. donovani strains with a similar genetic background but different ssg-susceptibil ... | 2013 | 24020363 |
| novel 3-nitro-1h-1,2,4-triazole-based piperazines and 2-amino-1,3-benzothiazoles as antichagasic agents. | we have previously shown that 3-nitro-1h-1,2,4-triazole-based amines demonstrate significant trypanocidal activity, in particular against trypanosoma cruzi, the causative parasite of chagas disease. in the present work we further expanded our research by evaluating in vitro the trypanocidal activity of nitrotriazole-based piperazines and nitrotriazole-based 2-amino-1,3-benzothiazoles to establish additional sars. all nitrotriazole-based derivatives were active or moderately active against t. cru ... | 2013 | 24012457 |
| on the catalytic mechanism of dimeric dutpases. | the tritryps trypanosoma brucei, trypanosoma cruzi and leishmania donovani are responsible for great morbidity and mortality in developing countries. their dimeric dutpases are members of the all-α ntp pyrophosphohydrolase family and represent promising drug targets due to their essential nature and markedly different structural and biochemical properties compared with the trimeric human enzyme. in the present paper we describe the structure of the t. brucei enzyme in open and closed conformatio ... | 2013 | 24001052 |
| substrate inhibition of uracil phosphoribosyltransferase by uracil can account for the uracil growth sensitivity of leishmania donovani pyrimidine auxotrophs. | the pathogenic protozoan parasite leishmania donovani is capable of both de novo pyrimidine biosynthesis and salvage of pyrimidines from the host milieu. genetic analysis has authenticated l. donovani uracil phosphoribosyltransferase (lduprt), an enzyme not found in mammalian cells, as the focal enzyme of pyrimidine salvage because all exogenous pyrimidines that can satisfy the requirement of the parasite for pyrimidine nucleotides are funneled to uracil and then phosphoribosylated to ump in the ... | 2013 | 23986453 |
| computational elucidation of structural basis for ligand binding with leishmania donovani adenosine kinase. | enzyme adenosine kinase is responsible for phosphorylation of adenosine to amp and is crucial for parasites which are purine auxotrophs. the present study describes development of robust homology model of leishmania donovani adenosine kinase to forecast interaction phenomenon with inhibitory molecules using structure-based drug designing strategy. docking calculation using reported organic small molecules and natural products revealed key active site residues such as arg131 and asp16 for ligand ... | 2013 | 23984386 |
| in vitro susceptibility of leishmania donovani to miltefosine in indian visceral leishmaniasis. | promastigote miltefosine (mil) susceptibility was performed on leishmania donovani isolates from indian patients with visceral leishmaniasis treated with mil. isolates that were obtained before the onset of mil treatment, after completion of treatment (29th day), or at the time of treatment failure, were screened using in vitro promastigote assay. the mil susceptibility of the pre-treatment isolates (n = 24, mean ic50 ± sem = 3.74 ± 0.38 μm) was significantly higher than that of the post-treatme ... | 2013 | 23980130 |
| cloning, characterization, and inhibition studies of a β-carbonic anhydrase from leishmania donovani chagasi, the protozoan parasite responsible for leishmaniasis. | leishmaniasis is an infection provoked by protozoans belonging to the genus leishmania. among the many species and subsepecies of such protozoa, leishmania donovani chagasi causes visceral leishmaniasis. a β-carbonic anhydrase (ca, ec 4.2.1.1) was cloned and characterized from this organism, denominated here ldcca. ldcca possesses effective catalytic activity for the co2 hydration reaction, with kcat of 9.35 × 10(5) s(-1) and kcat/km of 5.9 × 10(7) m(-1) s(-1). a large number of aromatic/heteroc ... | 2013 | 23977960 |
| leishmania donovani: influence of anti-leishmanial therapy on expression of lymphocyte function-associated antigen-3 and its relevance to pathogenisis in visceral leishmaniasis. | lymphocyte function associated antigen 3 (lfa-3) is known as adhesion molecule with its role in t-cell activation signaling as well as in foxp3 expression. its influences on il-10 production is also available, whose role in pathogenesis is well documented. however, this molecule is not yet directly addressed for its association with visceral leishmaniasis (vl). we investigated the relationship between leishmania donovani infection and expression of lfa-3 in vl patients in their pre and post trea ... | 2013 | 23974052 |
| evaluation of a diospyrin derivative as antileishmanial agent and potential modulator of ornithine decarboxylase of leishmania donovani. | world health organization has called for academic research and development of new chemotherapeutic strategies to overcome the emerging resistance and side effects exhibited by the drugs currently used against leishmaniasis. diospyrin, a bis-naphthoquinone isolated from diospyros montana roxb., and its semi-synthetic derivatives, were reported for inhibitory activity against protozoan parasites including leishmania. presently, we have investigated the antileishmanial effect of a di-epoxide deriva ... | 2013 | 23973194 |
| miltefosine resistance in leishmania donovani involves suppression of oxidative stress-induced programmed cell death. | miltefosine (mil), an alkylphospholipid, is the first orally administrable anti-leishmanial drug. but due to its long half-life, miltefosine is highly vulnerable for resistance. hence it is important to understand the mechanism of resistance and to elucidate its action on leishmania. here we investigate the miltefosine induced process of programmed cell death in wild type (miltefosine sensitive) and in laboratory generated resistant strains of leishmania donovani. results indicate that miltefosi ... | 2013 | 23968687 |
| the malnutrition-related increase in early visceralization of leishmania donovani is associated with a reduced number of lymph node phagocytes and altered conduit system flow. | in a murine model of moderate childhood malnutrition we found that polynutrient deficiency led to a 4-5-fold increase in early visceralization of l. donovani (3 days post-infection) following cutaneous infection and a 16-fold decrease in lymph node barrier function (p<0.04 for all). to begin to understand the mechanistic basis for this malnutrition-related parasite dissemination we analyzed the cellularity, architecture, and function of the skin-draining lymph node. there was no difference in th ... | 2013 | 23967356 |
| to investigate the therapeutic potential of immunochemotherapy with cisplatin + 78 kda + mpl-a against leishmania donovani in balb/c mice. | leishmaniasis has recently garnered attention as one of the diseases 'most neglected' by drug research and development, as the current therapeutic modalities available for the patients are ridden with unacceptable toxicity due to high dosage of the drug, prolonged treatment schedules, resistance and prohibitive costs. a successful chemotherapy requires a restoration of immune response; therefore, we combined leishmania-specific 78 kda antigen (with or without adjuvant mpl-a) along with a novel d ... | 2014 | 23964700 |
| inhibition of growth of leishmania donovani promastigotes by newly synthesized 1,3,4-thiadiazole analogs. | leishmania donovani, the causative agent of visceral leishmaniasis, is transmitted by sand flies and replicates intracellularly in their mammalian host cells. the emergence of drug-resistant strains has hampered efforts to control the spread of the disease worldwide. forty-four 1,3,4-thiadiazole derivatives and related compounds were tested in vitro for possible anti-leishmanial activity against the promastigotes of l. donovani. micromolar concentrations of these agents were used to study the in ... | 2009 | 23964165 |
| liposomal resiquimod for the treatment of leishmania donovani infection. | the imidazoquinoline family of drugs are toll-like receptor 7/8 agonists that have previously been used in the treatment of cutaneous leishmaniasis. because of the hydrophobic nature of imidazoquinolines, they are traditionally not administered systemically for the treatment of visceral leishmaniasis. we formulated liposomal resiquimod, an imidazoquinoline, for the systemic treatment of visceral leishmaniasis. | 2014 | 23956375 |
| two case reports on visceral leishmaniasis diagnosed in romania. | two cases of visceral leishmaniasis with a species from leishmania donovani complex were detected in the fundeni clinical institute. in one case, two infection sources were possible: one from italy, where the patient worked three years, the other from the southwest of romania (dolj county), where he was resident and where few human and canine leishmaniasis cases were registered in the past. in the second case, the patient lived in the northeast of romania (iaşi county), but worked in the same so ... | 2013 | 23947013 |
| molecular detection of leishmania infection in sand flies in border line of iran-turkmenistan: restricted and permissive vectors. | a molecular study was carried out to incriminate sand fly vectors of cutaneous leishmaniasis (cl) in rural areas of sarakhs district, khorassane-razavi province, northeastern iran, in 2011. sand flies of sergentomyia with three species and phlebotomus with six species respectively comprised 73.3% and 26.7% of the specimens. phlebotomus papatasi was the most common phlebotomine species in outdoor and indoor resting places. leishmania infection was found at least in 17 (22%) specimens including ph ... | 2013 | 23933280 |
| post-kala-azar dermal leishmaniasis with mucosal involvement: an unusual case presentation including successful treatment with miltefosine. | post-kala-azar dermal leishmaniasis (pkdl) is a dermatologic manifestation that usually occurs after visceral leishmaniasis (vl) caused by leishmania donovani. it is characterized by hypopigmented patches, a macular or maculopapular rash and nodular skin lesions on the body surface. involvement of the mucosae is very rare and unusual in pkdl. we report a case of pkdl that presented with polymorphic skin lesions, along with involvement of peri-oral mucosa and tongue from an endemic area for kala- ... | 2013 | 23930349 |
| antiprotozoal screening of 60 south african plants, and the identification of the antitrypanosomal germacranolides schkuhrin i and ii. | two hundred and seven extracts were prepared from sixty plants from south africa and screened for in vitro activity against trypanosoma brucei rhodesiense, trypanosoma cruzi, leishmania donovani, and plasmodium falciparum. for the 21 extracts which inhibited the growth of one or more parasites with more than 95 % at 10 µg/ml, the ic50 values against all four protozoal parasites and cytotoxic ic50 values against l6 myoblasts were determined. amongst the most notable results are the activities of ... | 2013 | 23929246 |
| cross-sectional study to assess risk factors for leishmaniasis in an endemic region in sri lanka. | sri lanka reports significantly more cutaneous leishmaniasis (cl) cases than visceral leishmaniasis (vl) cases, both of which are caused by leishmania donovani mon-37. a cross-sectional study conducted in an area with a high prevalence of cl prevalent included 954 participants of an estimated population of 61,674 to estimate the number of cl cases, ascertain whether there is a pool of asymptomatic vl cases, and identify risk factors for transmission. a total of 31 cases of cl were identified, of ... | 2013 | 23918217 |
| design, synthesis and biological evaluation of aryl pyrimidine derivatives as potential leishmanicidal agents. | a series of substituted aryl pyrimidine derivatives was synthesized and evaluated in vitro for their antileishmanial potential against intracellular amastigotes of leishmania donovani using reporter gene luciferase assay. among all, 8 compounds showed promising ic50 values ranging from 0.5 to 12.9 μm. selectivity indices (s.i.) of all these compounds are far better than reference drugs, sodium stibogluconate (ssg) and miltefosine. on the basis of good s.i., compounds were further screened for th ... | 2013 | 23910597 |
| miltefosine-unresponsive leishmania donovani has a greater ability than miltefosine-responsive l. donovani to resist reactive oxygen species. | resistance of leishmania parasites to miltefosine, which is only available oral drug, is a great concern. we have analyzed global gene expression profiles of miltefosine-unresponsive and miltefosine-responsive leishmania donovani in order to understand the various metabolic processes involved in miltefosine drug resistance. the microarray data clearly indicated a role of oxidative metabolism in miltefosine resistance. furthermore, fluorescence microscopy experiments suggested that miltefosine-un ... | 2013 | 23890327 |
| [severe oral mucositis in a patient with hiv infection]. | a 50-year-old man with hiv infection (first diagnosed > 20 years ago) presented at our hospital with fulminant oral mucositis. antiretroviral therapy (tenofovir, emtricitabine, raltegravir) had been started 2 months ago. previously he had no opportunistic infections and no other pre-existing illnesses. he had not travelled outside europe but stayed in spain for several weeks during summer. | 2013 | 23884748 |
| rklo8, a novel leishmania donovani - derived recombinant immunodominant protein for sensitive detection of visceral leishmaniasis in sudan. | for effective control of visceral leishmaniasis (vl) in east africa, new rapid diagnostic tests are required to replace current tests with low sensitivity. the aim of this study is to improve diagnosis of vl in east africa by testing a new antigen from an autochthonous l. donovani strain in sudan. | 2013 | 23875052 |
| synthesis and antiprotozoal activities of benzyl phenyl ether diamidine derivatives. | sixty-two cationic benzyl phenyl ether derivatives (36 amidines and 26 prodrugs) were prepared and assayed for activities in vitro and in vivo against trypanosoma brucei rhodesiense (stib900), and in vitro against plasmodium falciparum (k1) and leishmania donovani axenic amastigotes. 3-amidinobenzyl 4-amidino-2-iodo-6-methoxyphenyl ether dihydrochloride (55, ic50 = 3.0 nm) and seven other compounds exhibited ic50 values below 10 nm against t. b. rhodesiense in vitro. the 2-bromo-4,4'-diamidino a ... | 2013 | 23871911 |
| microalbuminuria and glomerular filtration rate in paediatric visceral leishmaniasis. | visceral leishmaniasis, caused by leishmania donovani, is a serious form of leishmaniasis and fatal if untreated. nearly half of the vl cases are children. there are very few studies of renal function in pediatric visceral leishmaniasis. the aim of this study was to evaluate renal dysfunction by studying glomerular filtration rate (gfr), microalbuminuria, and microscopic examination of urine. laboratory analysis was performed on blood and urine samples of 40 parasitologically confirmed pediatric ... | 2013 | 23865054 |
| the r enantiomer of the antitubercular drug pa-824 as a potential oral treatment for visceral leishmaniasis. | the novel nitroimidazopyran agent (s)-pa-824 has potent antibacterial activity against mycobacterium tuberculosis in vitro and in vivo and is currently in phase ii clinical trials for tuberculosis (tb). in contrast to m. tuberculosis, where (r)-pa-824 is inactive, we report here that both enantiomers of pa-824 show potent parasiticidal activity against leishmania donovani, the causative agent of visceral leishmaniasis (vl). in leishmania-infected macrophages, (r)-pa-824 is 6-fold more active tha ... | 2013 | 23856774 |
| synthesis and antiprotozoal activity of original porphyrin precursors and derivatives. | importance of heme in african trypanosomes, leishmania sp. and plasmodium sp. metabolisms justifies considering the potential of porphyrins and their precursors and derivatives as potential antiparasitic agents by interfering with heme metabolism. consequently, twenty-four porphyrin precursors and derivatives were evaluated against leishmania donovani, trypanosoma brucei and plasmodium sp. the best active compound against trypanosoma brucei brucei was a new porphyrin derivative; compound 4i, wit ... | 2013 | 23851117 |
| adenine and adenosine salvage in leishmania donovani. | 6-aminopurine metabolism in leishmania is unique among trypanosomatid pathogens since this genus expresses two distinct routes for adenine salvage: adenine phosphoribosyltransferase (aprt) and adenine deaminase (aah). to evaluate the relative contributions of aprt and aah, adenine salvage was evaluated in δaprt, δaah, and δaprt/δaah null mutants of l. donovani. the data confirm that aah plays the dominant role in adenine metabolism in l. donovani, although either enzyme alone is sufficient for s ... | 2013 | 23845934 |
| antimicrobial, antiparasitic, anti-inflammatory, and cytotoxic activities of lopezia racemosa. | the present study investigates the potential benefits of the mexican medicinal plant lopezia racemosa (onagraceae). extracts and fractions from aerial parts of this plant were assessed to determine their antibacterial, antifungal, antiparasitic, anti-inflammatory and cytotoxic activities in vitro. aerial parts of the plant were extracted with various solvents and fractionated accordingly. extracts and fractions were tested against a panel of nine bacterial and four fungal species. the antiparasi ... | 2013 | 23843731 |
| characterization of a novel putative s-adenosylmethionine decarboxylase-like protein from leishmania donovani. | in addition to the s-adenosylmethionine decarboxylase (ad) present in all organisms, trypanosomatids including leishmania spp. possess an additional copy, annotated as the putative s-adenosylmethionine decarboxylase-like proenzyme (adl). phylogenetic analysis confirms that adl is unique to trypanosomatids and has several unique features such as lack of autocatalytic cleavage and a distinct evolutionary lineage, even from trypanosomatid ads. in trypanosoma adl was found to be enzymaticaly dead bu ... | 2013 | 23840377 |
| 3-(oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid trypanosoma brucei, the causative agent for human african trypanosomiasis. | a whole organism high-throughput screen of approximately 87,000 compounds against trypanosoma brucei brucei led to the recent discovery of several novel compound classes with low micromolar activity against this organism and without appreciable cytotoxicity to mammalian cells. herein we report a structure-activity relationship (sar) investigation around one of these hit classes, the 3-(oxazolo[4,5-b]pyridin-2-yl)anilides. sharp sar is revealed, with our most active compound (5) exhibiting an ic₅ ... | 2013 | 23831695 |
| cyclophilin-mediated reactivation pathway of inactive adenosine kinase aggregates. | monomeric adenosine kinase (adk), a pivotal salvage enzyme of the purine auxotrophic parasite, leishmania donovani, tends to aggregate naturally or selectively in presence of adp, leading to inactivation. a cyclophilin (ldcyp) from the parasite reactivated the enzyme by disaggregating it. we studied the aggregation pathway of adk with or without adp. transmission electron microscopy revealed that adp-induced aggregates, as opposed to annular or torus-shaped natural aggregates, were mostly amorph ... | 2013 | 23831509 |
| in vivo and in vitro antileishmanial activity of bungarus caeruleus snake venom through alteration of immunomodulatory activity. | leishmaniasis threatens more than 350 million people worldwide specially in tropical and subtropical region. antileishmanial drugs that are currently available have various limitations. the search of new drugs from natural products (plants, animals) possessing antileishmanial activity is ventured throughout the world. the present study deals with the antileishmanial activity of bungarus caeruleus snake venom (bcv) on in vitro promastigotes and amastigotes of leishmania donovani parasite and leis ... | 2013 | 23830987 |
| the triterpenoid fraction from trichosanthes dioica root exhibits in vitro antileishmanial effect against leishmania donovani promastigotes. | trichosanthes dioica roxb. (cucurbitaceae), called pointed gourd in english is a dioecious climber found wild throughout the plains of the indian subcontinent and traditionally used in india for several medicinal purposes. | 2013 | 23798885 |
| antileishmanial activity, uptake, and biodistribution of an amphotericin b and poly(α-glutamic acid) complex. | a noncovalent, water-soluble complex of amphotericin b (amb) and poly(α-glutamic acid) (pga), with amb loadings ranging from 25 to 55% (wt/wt) using pga with a molecular weight range of 50,000 to 70,000, was prepared as a potential new treatment for visceral leishmaniasis (vl). the amb-pga complex was shown to be as active as fungizone (amb deoxycholate) against intracellular leishmania donovani amastigotes in differentiated thp-1 cells. the in vitro uptake of the amb-pga complex by differentiat ... | 2013 | 23796924 |
| sergentomyia schwetzi is not a competent vector for leishmania donovani and other leishmania species pathogenic to humans. | sand fly species of the genus sergentomyia are proven vectors of reptilian leishmania that are non-pathogenic to humans. however, a consideration of the role of sergentomyia spp. in the circulation of mammalian leishmaniasis appears repeatedly in the literature and the possibility of leishmania transmission to humans remains unclear. here we studied the susceptibility of colonized sergentomyia schwetzi to leishmania donovani and two other leishmania species pathogenic to humans: l. infantum and ... | 2013 | 23786805 |
| gene expression modulation and the molecular mechanisms involved in nelfinavir resistance in leishmania donovani axenic amastigotes. | drug resistance is a major public health challenge in leishmaniasis chemotherapy, particularly in the case of emerging leishmania/hiv-1 co-infections. we have delineated the mechanism of cell death induced by the hiv-1 protease inhibitor, nelfinavir, in the leishmania parasite. in order to further study nelfinavir-leishmania interactions, we selected nelfinavir-resistant axenic amastigotes in vitro and characterized them. rna expression profiling analyses and comparative genomic hybridizations o ... | 2013 | 23782314 |
| drug resistance in natural isolates of leishmania donovani s.l. promastigotes is dependent of pgp170 expression. | resistance of pathogens to drugs is a growing concern regarding many diseases. parasites like leishmania, plasmodium and entamoeba histolytica; and neoplastic cells, present the multidrug-resistant phenotype rendering chemotherapy ineffective. the acquired resistance of leishmania to antimony has generated intense research on the mechanisms involved but the question has not yet been resolved. to test the hypothesis that drug efflux in leishmania, as measured by flow cytometry using the fluoresce ... | 2013 | 23776486 |
| comparative study of microscopy and polymerase chain reaction for the diagnosis of suspected visceral leishmaniasis patients in nepal. | visceral leishmaniasis is potentially fatal protozoan diseases caused by leishmania donovani. nepal is an endemic region in which visceral leishmaniasis causes a major public health problem in the lowland areas that border the endemic areas of bihar state in india. accurate diagnosis to inform treatment is a first step in achieving the goal of visceral leishmaniasis elimination from south east asian regions by 2020. | 2013 | 23774406 |
| drug repurposing: mining protozoan proteomes for targets of known bioactive compounds. | to identify potential opportunities for drug repurposing by developing an automated approach to pre-screen the predicted proteomes of any organism against databases of known drug targets using only freely available resources. | 2016 | 23757409 |
| chemo-informatic design of antibiotic geldenamycin analogs to target stress proteins hsp90 of pathogenic protozoan parasites. | stress proteins hsp90 (heat shock proteins) are essential molecular chaperones involved in signal transduction, cell cycle control, stress management, folding and degradation of proteins. hsp90 have been found in a variety of organisms including pathogens suggesting that they are ancient and conserved proteins. here, using molecular modeling and docking protocols, antibiotic geldenamycin and its analog are targeted to the hsp90 homolog proteins of pathogenic protozoans plasmodium falciparum, lei ... | 2013 | 23750075 |
| in vitro drug susceptibility of leishmania infantum isolated from humans and dogs. | visceral leishmaniasis (vl) caused by parasites of leishmania donovani complex is a severe human disease which often leads to death if left untreated. domestic dogs are the main reservoir hosts for zoonotic human visceral infection caused by leishmania infantum. in the absence of effective human and dog vaccines, the only feasible way to treat and control leishmaniasis is through the use of suitable medications. to know the drug susceptibility of human and canine leishmania strains from lisbon-p ... | 2013 | 23747751 |
| structure prediction of gbp21 protein of l. donovani and its molecular interaction. | visceral leishmaniasis (kala-azar) is a fatal disease caused by the obligate intracellular parasite leishmania donovani and the available drugs for the treatment are few, and are frequently associated with side effects and toxicity. rna editing is one of the essential metabolic processes in the kinetoplastids, where the pre-mrnas are edited post-transcriptionally by the guide rnas with the addition or deletion of uridine residues. the aim is to block the gbp21 protein involved in rna editing pro ... | 2014 | 23746168 |
| novel approaches for the identification of inhibitors of leishmanial dipeptidylcarboxypeptidase. | leishmaniasis imposes a substantial burden of mortality and morbidity affecting 12 million globally and continues to be a neglected tropical disease. control of the disease is mainly based on chemotherapy, which relies on a handful of drugs with serious limitations. over the last decade, target-based drug discovery is also being employed in addition to the random screening of compounds. leishmanial dipeptidylcarboxypeptidase (ldcp), an angiotensin converting enzyme (ace) related metallopeptidase ... | 2013 | 23745836 |
| inhibition of leishmania infantum trypanothione reductase by azole-based compounds: a comparative analysis with its physiological substrate by x-ray crystallography. | herein we report a study aimed at discovering a new class of compounds that are able to inhibit leishmania donovani cell growth. evaluation of an in-house library of compounds in a whole-cell screening assay highlighted 4-((1-(4-ethylphenyl)-2-methyl-5-(4-(methylthio)phenyl)-1h-pyrrol-3-yl)methyl)thiomorpholine (compound 1) as the most active. enzymatic assays on leishmania infantum trypanothione reductase (litr, belonging to the leishmania donovani complex) shed light on both the interaction wi ... | 2013 | 23733388 |
| effectiveness of miltefosine treatment in targeting anti-leishmanial ho-1/nrf-2-mediated oxidative responses in visceral leishmaniasis patients. | miltefosine, an alkylphosphocholine anti-cancer drug, exhibits direct activity against leishmania donovani and also promotes anti-leishmanial host immunomodulatory functions. nuclear factor-erythroid 2-related factor 2 (nrf-2), a redox-sensitive transcription factor, regulates the host stress responses leading to effective microbial clearance by a positive effect on haem oxygenase-1 (ho-1) enzyme expression/activity. we aimed to investigate the role of miltefosine in regulating ho-1/nrf-2-mediat ... | 2013 | 23729024 |
| synthesis of novel guttiferone a derivatives: in-vitro evaluation toward plasmodium falciparum, trypanosoma brucei and leishmania donovani. | the catechol pharmacomodulation of the natural product guttiferone a, isolated from the symphonia globulifera tree, led to the semisynthesis of a collection of twenty derivatives. the ester and ether derivatives of guttiferone a were evaluated for their anti-plasmodial, trypanocidal and anti-leishmanial activities. some compounds described below have shown potent antiparasitic activity against plasmodium falciparum, trypanosoma brucei and leishmania donovani in a range from 1 to 5 μm. the evalua ... | 2013 | 23727538 |
| recent developments in the antiprotozoal and anticancer activities of the 2-alkynoic fatty acids. | the 2-alkynoic fatty acids are an interesting group of synthetic compounds that display antimycobacterial, antifungal, anticancer, and pesticidal activities but their antiprotozoal activity has received little attention until recently. in this review we have summarized our present knowledge of the biomedical potential of the 2-hexadecynoic acid (2-hda) and 2-octadecynoic acid (2-oda) together with several mechanistic pieces of work attesting to the fact that these compounds, and their metabolite ... | 2016 | 23727443 |
| evaluation of toxicity & therapeutic efficacy of a new liposomal formulation of amphotericin b in a mouse model. | current therapy for leishmaniasis is limited and unsatisfactory. amphotericin b, a second-line treatment is gradually replacing antimonials, the first-line treatment and is used as the preferred treatments in some regions. though, presently it is the only drug with highest cure rate, its use is severely restricted by its acute toxicity. in the present study novel lipid-amphotericin b formulations with lower toxicity than the parent drug were evaluated for the treatment of visceral leishmaniasis ... | 2013 | 23703346 |
| cloning, overexpression, purification and crystallization of the crn12 coiled-coil domain from leishmania donovani. | leishmania donovani coronin crn12 is an actin-binding protein which consists of two domains: an n-terminal wd repeat domain and a c-terminal coiled-coil domain. the coiled-coil domain is 53 residues in length. helix-helix interactions in general and coiled coils in particular are ubiquitous in the structure of proteins and play a significant role in the association among proteins, including supramolecular assemblies and transmembrane receptors that mediate cellular signalling, transport and acti ... | 2013 | 23695571 |
| enrichment of leishmania donovani atp-binding proteins using a staurosporine capture compound. | trypanosomatid parasites of the genus leishmania cause severe human diseases collectively termed leishmaniasis. parasite atp-binding proteins have emerged as potent targets for chemotherapeutic intervention. however, many parasite-specific atp-binding proteins may escape current efforts in drug target identification, validation and deconvolution due to the lack of sequence conservation and functional annotation of these proteins in early branching eukaryotic trypanosomatids. here, we selectively ... | 2013 | 23684787 |
| bone marrow negative visceral leishmaniasis in an adolescent male. | visceral leishmaniasis or kala azar is endemic in certain regions of india. in endemic areas, the constellation of fever, progressive weight loss, weakness, pronounced splenomegaly, anemia, leukopenia, and hypergammaglobulinemia is highly suggestive of visceral leishmaniasis. demonstration of the parasite in liver, splenic or bone marrow aspirates is confirmatory. we present a case in which leishmania donovani (ld) bodies were demonstrated on splenic aspirate. we were unable to demonstrate ld bo ... | 2013 | 23682278 |
| synthesis and biological evaluation of a novel series of aryl s,n-ketene acetals as antileishmanial agents. | a series of aryl s,n-ketene acetals 7(a-f) was synthesized and evaluated for their in vitro and in vivo antileishmanial activity against leishmania donovani. all the 6 compounds exhibited significant in vitro activity against intracellular amastigotes of l. donovani with ic50 values ranging from 1.2 to 3.5 μm and were found promising as compared with reference drugs, sodium stibogluconate (ssg) and paromomycin. on the basis of good selectivity indices (si), they were further tested for their in ... | 2013 | 23673014 |
| human immunodeficiency virus/leishmania infantum in the first foci of urban american visceral leishmaniasis: clinical presentation from 1994 to 2010. | human immunodeficiency virus (hiv) coinfection with leishmania infantum or leishmania donovani, the agents of visceral leishmaniasis (or kala-azar), has become a fatal public health problem in the tropics where kala-azar is endemic. | 2013 | 23666663 |
| moving from unsequenced to sequenced genome: reanalysis of the proteome of leishmania donovani. | the kinetoplastid protozoan parasite, leishmania donovani, is the causative agent of kala azar or visceral leishmaniasis. kala azar is a severe form of leishmaniasis that is fatal in the majority of untreated cases. studies on proteomic analysis of l. donovani thus far have been carried out using homology-based identification based on related leishmania species (l. infantum, l. major and l. braziliensis) whose genomes have been sequenced. recently, the genome of l. donovani was fully sequenced a ... | 2013 | 23665000 |
| successful substitution of fetal calf serum by human plasma for bulk cultivation of leishmania donovani promastigotes. | the potential of human plasma (hp) or serum (hs) as a replacement for fetal calf serum (fcs) was evaluated in a liver infusion tryptose (lit) medium for bulk cultivation of leishmania donovani promastigotes. the promastigote yield with the lit-fcs standard medium was 0.4-1.8×10(7) ml(-1), and yields of 0.5-3.4×10(7) (p = 0.527) and 0.4-2.4×10(7) (p = 0.062) were recorded for two lit medium variants containing hp or hs as supplement instead of fcs. significantly, higher promastigote yields of 1.3 ... | 2013 | 23657530 |
| the loss of virulence of histone h1 overexpressing leishmania donovani parasites is directly associated with a reduction of hsp83 rate of translation. | overexpression of leishmania histone h1 (leishh1) was previously found to cause a promastigote-to-amastigote differentiation handicap, deregulation of cell-cycle progression, and loss of parasite infectivity. the aim of this study was to identify changes in the proteome of leishh1 overexpressing parasites associated with the avirulent phenotype observed. 2d-gel electrophoresis analysis revealed only a small protein subset of differentially expressed proteins in the leishh1 overexpressing promast ... | 2013 | 23647017 |
| phlebotomus orientalis sand flies from two geographically distant ethiopian localities: biology, genetic analyses and susceptibility to leishmania donovani. | phlebotomus orientalis parrot (diptera: psychodidae) is the main vector of visceral leishmaniasis (vl) caused by leishmania donovani in east africa. here we report on life cycle parameters and susceptibility to l. donovani of two p. orientalis colonies originating from different sites in ethiopia: a non-endemic site in the lowlands - melka werer (mw), and an endemic focus of human vl in the highlands - addis zemen (az). | 2013 | 23638207 |
| discovery of a new class of natural product-inspired quinazolinone hybrid as potent antileishmanial agents. | the high potential of quinazolinone containing natural products and their derivatives in medicinal chemistry led us to discover four novel series of 53 compounds of quinazolinone based on the concept of molecular hybridization. most of the synthesized analogues exhibited potent leishmanicidal activity against intracellular amastigotes (ic50 from 0.65 ± 0.2 to 7.76 ± 2.1 μm) as compared to miltefosine (ic50 = 8.4 ± 2.1 μm) and nontoxic toward the j-774a.1 cell line and vero cells. moreover, activ ... | 2013 | 23611626 |
| bone marrow aspirate showing leishmania donovani in polymorphs. | 2013 | 23589788 | |
| regulatory actions of toll-like receptor 2 (tlr2) and tlr4 in leishmania donovani infection in the liver. | in livers of susceptible but self-curing c57bl/6 mice, intracellular leishmania donovani infection enhanced toll-like receptor 4 (tlr4) and tlr2 gene expression. in the liver, infected tlr4(-/-) mice showed reduced gamma interferon (ifn-γ), tumor necrosis factor (tnf), and inducible nitric oxide synthase (inos) mrna expression, higher-level and slowly resolving infection, delayed granuloma formation, and little response to low-dose chemotherapy; in serum, the ratio of ifn-γ to interleukin 10 (il ... | 2013 | 23589575 |
| seasonal variation in the prevalence of sand flies infected with leishmania donovani. | visceral leishmaniasis (vl) is a life threatening neglected infectious disease in the indian subcontinent, transmitted by the bite of female sand flies. estimation of the infectivity in the vector population, collected in different seasons, may be useful to better understanding the transmission dynamics of vl as well as to plan vector control measures. | 2013 | 23585896 |
| chemotherapy of leishmaniasis. part xii: design, synthesis and bioevaluation of novel triazole integrated phenyl heteroterpenoids as antileishmanial agents. | a novel series of triazole integrated phenyl heteroterpenoids have been synthesized and screened for their in vitro activity against intracellular amastigote form of leishmania donovani. among all tested compounds, compound 3a was found to be the most active with ic50 6.4μm and better selectivity index (si) 18 as compared to reference drugs, miltefosine and miconazole. when evaluated in vivo in l. donovani/hamster model, 3a has exhibited 79±11% inhibition of parasite multiplication at 50mgkg(-1) ... | 2013 | 23582274 |
| comparison of a high-throughput high-content intracellular leishmania donovani assay with an axenic amastigote assay. | visceral leishmaniasis is a neglected tropical disease with significant health impact. the current treatments are poor, and there is an urgent need to develop new drugs. primary screening assays used for drug discovery campaigns have typically used free-living forms of the leishmania parasite to allow for high-throughput screening. such screens do not necessarily reflect the physiological situation, as the disease-causing stage of the parasite resides inside human host cells. assessing the drug ... | 2013 | 23571538 |
| [what is your diagnosis? leishmania donovani visceral leishmaniasis]. | 2013 | 23570920 | |
| in vitro leishmanicidal activity of some cameroonian medicinal plants. | eleven plants used in the cameroonian traditional medicine for the treatment of some parasitic infections were tested for their activity on the promastigote form of leishmania donovani. after incubation with different plant extracts at doses of 1600, 800, 400 and 200 microgram/ml, the evaluation of the cell viability was done by the trypan blue exclusion technique and by flow cytometry. this study shows that 48 h after incubation of promastigotes with plant extract, solanocia mannii and solanum ... | 2013 | 23562881 |
| leishmania donovani whole cell antigen delivered with adjuvants protects against visceral leishmaniasis in vervet monkeys (chlorocebus aethiops). | in a previous immunogenicity and efficacy study in mice, montanide isa 720 (misa) was indicated to be a better adjuvant than bacillus calmette guerin vaccine (bcg) for a leishmania vaccine. in the present study, we report the safety, immunogenicity and efficacy of leishmania donovani (l. donovani) sonicated antigen delivered with alum-bcg (albcg), misa or monophosphoryl lipid a (mpla) in vervet monkeys following intradermal inoculums. vaccinated and control animals were challenged with virulent ... | 2012 | 23554725 |
| role of remote sensing, geographical information system (gis) and bioinformatics in kala-azar epidemiology. | visceral leishmaniasis or kala-azar is a potent parasitic infection causing death of thousands of people each year. medicinal compounds currently available for the treatment of kala-azar have serious side effects and decreased efficacy owing to the emergence of resistant strains. the type of immune reaction is also to be considered in patients infected with leishmania donovani (l. donovani). for complete eradication of this disease, a high level modern research is currently being applied both at ... | 2011 | 23554714 |
| phylogenetic analysis of lack gene sequences for 22 chinese leishmania isolates. | the phylogenetic relationships between chinese leishmania strains were investigated using lack (leishmania homolog of receptors for activated protein kinase c) gene sequences, and the power of this gene was assessed for understanding the epidemiology and population genetics of leishmania. | 2013 | 23541410 |
| antileishmanial activity evaluation of bis-lawsone analogs and dna topoisomerase-i inhibition studies. | for the development of potent novel antileishmanial agents, 3,3'-(arylmethylene)bis(2-hydroxynaphthalene-1,4 dione) derivatives were synthesized from lawsone and evaluated for cytotoxicity on leishmania donovani promastigotes as well as on leishmanial dna topoisomerase-i. enzyme inhibition studies were conducted with simultaneous and preincubation conditions. total inhibition is compared to camptothecin (cpt), which was taken as positive control on both the systems of enzyme inhibition. the rang ... | 2014 | 23534930 |
| development of doxorubicin loaded novel core shell structured nanocapsules for the intervention of visceral leishmaniasis. | the aim of this study was to develop novel nanoemuslion core loaded nanocapsules (ncs) with high payload of doxorubicin (dox) and to assess its efficacy against leishmania donovani. the low energy emulsification method was used to obtained nanoemulsion core as template, followed by stepwise addition of additional layer components protamine sulphate and sodium alginate. zeta potential studies revealed that there was reversal in charge after each layering. ncs were characterized on the basis of si ... | 2013 | 23534494 |
| synthesis and biological evaluation of tricyclic guanidine analogues of batzelladine k for antimalarial, antileishmanial, antibacterial, antifungal, and anti-hiv activities. | fifty analogues of batzelladine k were synthesized and evaluated for in vitro antimalarial (plasmodium falciparum), antileishmanial (leishmania donovani), antimicrobial (panel of bacteria and fungi), antiviral (hiv-1) activities. analogues 14h and 20l exhibited potential antimalarial activity against chloroquine-sensitive d6 strain with ic(50) 1.25 and 0.88 μm and chloroquine-resistant w2 strain with ic(50) 1.64 and 1.07 μm, respectively. analogues 12c and 14c having nonyl substitution showed th ... | 2013 | 23534411 |
| leishmania donovani infection induces anemia in hamsters by differentially altering erythropoiesis in bone marrow and spleen. | leishmania donovani is a parasite that causes visceral leishmaniasis by infecting and replicating in macrophages of the bone marrow, spleen, and liver. severe anemia and leucopenia is associated with the disease. although immune defense mechanisms against the parasite have been studied, we have a limited understanding of how l. donovani alters hematopoiesis. in this study, we used syrian golden hamsters to investigate effects of l. donovani infection on erythropoiesis. infection resulted in seve ... | 2013 | 23533629 |
| evaluation of pcr procedures for detecting and quantifying leishmania donovani dna in large numbers of dried human blood samples from a visceral leishmaniasis focus in northern ethiopia. | visceral leishmaniasis (vl) is a disseminated protozoan infection caused by leishmania donovani parasites which affects almost half a million persons annually. most of these are from the indian sub-continent, east africa and brazil. our study was designed to elucidate the role of symptomatic and asymptomatic leishmania donovani infected persons in the epidemiology of vl in northern ethiopia. | 2013 | 23530965 |
| studies on the protective and immunomodulatory efficacy of withania somnifera along with cisplatin against experimental visceral leishmaniasis. | visceral leishmaniasis (vl) or kala-azar continues to persist as one of the major public health problems in many tropical countries. however, no effective treatment for cure of the disease is yet available. the present study was designed to investigate the nephroprotective and immunomodulatory effect of withania somnifera in cisplatin-treated leishmania donovani-infected balb/c mice. administration of cisplatin (5 mg/kg body weight (b.wt.) daily for 5 days, i.p.) reduced the parasite load in l. ... | 2013 | 23519426 |
| discovery of 3,3'-diindolylmethanes as potent antileishmanial agents. | an efficient protocol for synthesis of 3,3'-diindolylmethanes using recyclable fe-pillared interlayered clay (fe-pilc) catalyst under aqueous medium has been developed. all synthesized 3,3'-diindolylmethanes showed promising antileishmanial activity against leishmania donovani promastigotes as well as axenic amastigotes. structure-activity relationship analysis revealed that nitroaryl substituted diindolylmethanes showed potent antileishmanial activity. the 4-nitrophenyl linked 3,3'-diindolylmet ... | 2013 | 23517732 |
| the race to discover the insect vector of kala-azar: a great saga of tropical medicine 1903-1942. | in the 19(th) century, a devastating epidemic of visceral leishmaniasis (kala-azar) swept through northeast india. after identification of the pathogenic agent, leishmania donovani, in 1903, the question of its transmission remained to be resolved. in 1904, thanks to work by l. rogers on cultures of this parasite it became probable that a haematophagous arthropod was responsible for transmission. j.a. sinton suggested, in 1925, the distribution of the sand fly phlebotomus argentipes was similar ... | 2013 | 23516011 |
| antiprotozoal isoflavan quinones from abrus precatorius ssp. africanus. | a library of 206 extracts from selected south african plants was screened in vitro against a panel of protozoan parasites, plasmodium falciparum, trypanosoma brucei rhodesiense, and leishmania donovani. a ch2cl2/meoh (1 : 1) extract of abrus precatorius l. ssp. africanus strongly inhibited p. falciparum (98 %), t. b. rhodesiense (100 %), and l. donovani (76 %) when tested at a concentration of 10.0 µg/ml. the active constituents were tracked by hplc-based activity profiling and isolated by prepa ... | 2013 | 23512498 |
| leishmania in hlh: a rare finding with significant treatment implications. | hemophagocytic lymphohistiocytosis (hlh) associated with visceral leishmaniasis (vl) is a very rare phenomenon. we report the first known north american case in a 21 month old boy. he was initially diagnosed with epstein barr virus (ebv) triggered hlh and treated with the international treatment protocol, hlh-2004. stem cell transplant was planned due to repeated reactivations of disease, but his pretransplant bone marrow revealed an unexpected protozoan-leishmania donovani. treatment with lipos ... | 2013 | 23511497 |
| antiprotozoal activity of khaya anthotheca, (welv.) c.d.c. a plant used by chimpanzees for self-medication. | khaya species, endemic to africa and madagascar, continues to be valuable in indigenous traditional medicine. their bitter tasting barks are decocted to treat fevers, several febrile conditions, microbial infections and worm infestations. in the budongo rain forest of western uganda, non-human primates, especially chimpanzees and baboons, have been observed to eat the bitter non-nutritious bark and occasionally the seed. | 2013 | 23501156 |
| chromone linked nitrone derivative induces the expression of inos2 and th1 cytokines but reduces the th2 response in experimental visceral leishmaniasis. | in our previous work we have shown that the novel synthetic chromone derivative could effectively inhibit the leishmania donovani replication in vitro and in vivo with less cytotoxicity on murine splenocytes. the aim of the present study is to explore the possible mechanism of anti-leishmanial effect of c-(6-methyl-4-oxo-4h-1-benzopyran-3-yl)-n-(p-tolyl) nitrone (designated as np1) in vitro and in vivo in experimental visceral leishmaniasis caused by l. donovani. the cytotoxic effect of this der ... | 2013 | 23499679 |
| heterologous priming-boosting with dna and vaccinia virus expressing kinetoplastid membrane protein-11 induces potent cellular immune response and confers protection against infection with antimony resistant and sensitive strains of leishmania (leishmania) donovani. | emergence of resistance against commonly available drugs poses a major threat in the treatment of visceral leishmaniasis (vl), particularly in the indian subcontinent. absence of any licensed vaccine against vl emphasizes the urgent need to develop an effective alternative vaccination strategy. | 2013 | 23499564 |
| leishmania donovani targets dicer1 to downregulate mir-122, lower serum cholesterol, and facilitate murine liver infection. | leishmania donovani causes visceral leishmaniasis (vl) where the parasite infects and resides inside liver and spleen tissue macrophages. given the abnormal lipid profile observed in vl patients, we examined the status of serum lipids in an experimental murine model of vl. the murine vl liver displayed altered expression of lipid metabolic genes, many of which are direct or indirect targets of the liver-specific microrna-122. concomitant reduction of mir-122 expression was observed in vl liver. ... | 2013 | 23498953 |
| leishmania dices away cholesterol for survival. | host lipid alterations are centrally involved in leishmania donovani infection, and infected patients exhibit hypocholesterolemia. in this issue of cell host & microbe, ghosh et al. (2013) show that the metalloprotease gp63 released by l. donovani in the liver cleaves dicer1, inhibiting mir-122 maturation, which regulates cholesterol metabolism. these events decrease serum cholesterol and promote parasite growth. | 2013 | 23498949 |
| comparison of visceral leishmaniasis diagnostic antigens in african and asian leishmania donovani reveals extensive diversity and region-specific polymorphisms. | visceral leishmaniasis (vl), caused by infection with leishmania donovani complex, remains a major public health problem in endemic regions of south asia, east africa, and brazil. if untreated, symptomatic vl is usually fatal. rapid field diagnosis relies principally on demonstration of anti-leishmania antibodies in clinically suspect cases. the rk39 immunochromatographic rapid diagnostic test (rdt) is based on rk39, encoded by a fragment of a kinesin-related gene derived from a brazilian l. cha ... | 2013 | 23469296 |
| molecular and serological markers of leishmania donovani infection in healthy individuals from endemic areas of bihar, india. | recent epidemiological reports indicate that asymptomatic human infections with leishmania donovani, the causative agent of visceral leishmaniasis or kala-azar (ka), occur frequently in india. we explored markers of infection. | 2013 | 23464581 |
| latent infection with leishmania donovani in highly endemic villages in bihar, india. | asymptomatic persons infected with the parasites causing visceral leishmaniasis (vl) usually outnumber clinically apparent cases by a ratio of 4-10 to 1. we describe patterns of markers of leishmania donovani infection and clinical vl in relation to age in bihar, india. | 2013 | 23459501 |
| parenteral formulation of an antileishmanial drug candidate--tackling poor solubility, chemical instability, and polymorphism. | the paullon chalcone derivative kurei300 is active against leishmania donovani, the protozoans causing visceral leishmaniasis. the aim of this study was the development of a parenteral formulation of the virtually water insoluble compound in order to enable future studies in mice. mixed lecithin/bile salt micelles, liposomes, supercooled smectic cholesterol myristate nanoparticles, cubic phase nanoparticles and a triglyceride emulsion were screened for their solubilizing properties. due to the l ... | 2013 | 23454203 |
| anti-protozoal activity of aporphine and protoberberine alkaloids from annickia kummeriae (engl. & diels) setten & maas (annonaceae). | malaria, trypanosomiasis and leishmaniasis have an overwhelming impact in the poorest countries in the world due to their prevalence, virulence and drug resistance ability. currently, there is inadequate armory of drugs for the treatment of malaria, trypanosomiasis and leishmaniasis. this underscores the continuing need for the discovery and development of new anti-protozoal drugs. consequently, there is an urgent need for research aimed at the discovery and development of new effective and safe ... | 2013 | 23445637 |
| examination of the mode of action of the almiramide family of natural products against the kinetoplastid parasite trypanosoma brucei. | almiramide c is a marine natural product with low micromolar activity against leishmania donovani, the causative agent of leishmaniasis. we have now shown that almiramide c is also active against the related parasite trypanosoma brucei, the causative agent of human african trypanosomiasis. a series of activity-based probes have been synthesized to explore both the molecular target of this compound series in t. brucei lysates and site localization through epifluorescence microscopy. these target ... | 2013 | 23445522 |
| eleganolone, a diterpene from the french marine alga bifurcaria bifurcata inhibits growth of the human pathogens trypanosoma brucei and plasmodium falciparum. | organic extracts of 20 species of french seaweed have been screened against trypanosoma brucei rhodesiense trypomastigotes, the parasite responsible for sleeping sickness. these extracts have previously shown potent antiprotozoal activities in vitro against plasmodium falciparum and leishmania donovani. the selectivity of the extracts was also evaluated by testing cytotoxicity on a mammalian l6 cell line. the ethyl acetate extract of the brown seaweed, bifurcaria bifurcata, showed strong trypano ... | 2013 | 23442789 |
| application of loop-mediated isothermal amplification assay for the sensitive and rapid diagnosis of visceral leishmaniasis and post-kala-azar dermal leishmaniasis. | loop-mediated isothermal amplification (lamp) is at the forefront in the search for innovative diagnostics for rapid and specific amplification of target dna under isothermal conditions. we have applied lamp assay using sybr green for clear-cut naked eye detection of leishmania (leishmania) donovani in 200 clinical samples of visceral leishmaniasis (vl) and post-kala-azar dermal leishmaniasis (pkdl). the assay was positive in 53/55 vl blood samples (sensitivity, 96.4%; 95% confidence interval [c ... | 2013 | 23433714 |